Table II.
Use of Antihypertensive and Antidiabetic Drugs in the Study Population
| Drugs | MHT | Normotension |
|---|---|---|
| Antihypertensive drug, % | 29 | 26 |
| Number of antihypertensive drugs per person | 0.5±0.9 | 0.4±0.7 |
| ACE inhibitors, % | 11 | 7 |
| Angiotensin receptor antagonists, % | 5 | 9 |
| Calcium channel blockers, % | 24 | 12 |
| Diuretics, % | 5 | 5 |
| β‐Blockers, % | 3 | 0 |
| α‐Blockers, % | 3 | 0 |
| Antidiabetic drug, % | 74 | 65 |
| Number of antidiabetic drugs per person | 1.3±1.0 | 1.1±1.0 |
| Sulfonylureas, % | 37 | 51 |
| α‐Glucosidase inhibitors, % | 42 | 33 |
| Aldose reductase inhibitors, % | 16a | 2 |
| Metformin, % | 32 | 21 |
| Pioglitazone, % | 0 | 2.0 |
| Insulin therapy, % | 39a | 14 |
| a P<.05 vs normotensive group. Abbreviations: ACE, angiotensin‐converting enzyme; MHT, masked hypertension. | ||